KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elevance Health (ELV) Operating Income (2016 - 2025)

Elevance Health (ELV) has disclosed Operating Income for 17 consecutive years, with -$3.0 billion as the latest value for Q2 2025.

  • On a quarterly basis, Operating Income changed N/A to -$3.0 billion in Q2 2025 year-over-year; TTM through Jun 2025 was -$33.5 billion, a N/A change, with the full-year FY2024 number at $2.1 billion, up 12.38% from a year prior.
  • Operating Income was -$3.0 billion for Q2 2025 at Elevance Health, down from $590.0 million in the prior quarter.
  • In the past five years, Operating Income ranged from a high of $33.7 billion in Q4 2023 to a low of -$43.9 billion in Q4 2021.
  • A 5-year average of -$9.9 billion and a median of -$3.2 billion in 2023 define the central range for Operating Income.
  • Biggest YoY gain for Operating Income was 211.84% in 2023; the steepest drop was 9613.39% in 2023.
  • Elevance Health's Operating Income stood at -$43.9 billion in 2021, then soared by 31.2% to -$30.2 billion in 2022, then surged by 211.84% to $33.7 billion in 2023, then crashed by 193.56% to -$31.6 billion in 2024, then skyrocketed by 90.5% to -$3.0 billion in 2025.
  • Per Business Quant, the three most recent readings for ELV's Operating Income are -$3.0 billion (Q2 2025), $590.0 million (Q1 2025), and -$31.6 billion (Q3 2024).